ArticleJournal of cancer research and clinical oncology2024

Niraparib enhances antitumor immunity and contributes to the efficacy of PD-L1 blockade in cervical cancer.

Jie Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.